Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Breast Cancer

Breast cancer drug not recommended for use in England

The drug fulvestrant (Faslodex) has not been recommended in England to treat late stage breast cancer, in draft guidance.

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

Targeted radiotherapy limits side effects of breast cancer treatment

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment.

Stem cell treatment kills cancer cells that have spread in mice

A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study.

News digest – Frozen needles, a smokefree UK, microbubbles and… breaking cancer’s ‘legs’?

Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

Pages